Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank71
3Y CAGR+6.6%
5Y CAGR-10.9%
Studio
Year-over-Year Change

Free cash flow yield

3Y CAGR
+6.6%/yr
Annual compound
5Y CAGR
-10.9%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20257.31%-24.5%
20249.68%+179.5%
20233.46%-42.6%
20226.03%-28.8%
20218.48%-34.9%
202013.02%+45.3%
20198.96%+168.5%
2018-13.09%-219.6%
2017-4.10%+80.3%
2016-20.75%-